Keybank National Association OH Cuts Stake in Chemed Corporation $CHE

Keybank National Association OH cut its position in Chemed Corporation (NYSE:CHE) by 93.6% in the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 614 shares of the company’s stock after selling 8,910 shares during the period. Keybank National Association OH’s holdings in Chemed were worth $275,000 as of its most recent SEC filing.

A number of other institutional investors have also recently made changes to their positions in the company. Creekmur Asset Management LLC purchased a new position in Chemed in the 2nd quarter worth approximately $28,000. First Horizon Corp bought a new stake in shares of Chemed in the 3rd quarter worth $31,000. Parkside Financial Bank & Trust raised its stake in shares of Chemed by 86.3% in the second quarter. Parkside Financial Bank & Trust now owns 95 shares of the company’s stock worth $46,000 after purchasing an additional 44 shares during the last quarter. Geneos Wealth Management Inc. lifted its holdings in shares of Chemed by 330.4% during the first quarter. Geneos Wealth Management Inc. now owns 99 shares of the company’s stock valued at $61,000 after purchasing an additional 76 shares in the last quarter. Finally, Pilgrim Partners Asia Pte Ltd bought a new stake in Chemed in the 3rd quarter worth about $45,000. Hedge funds and other institutional investors own 95.85% of the company’s stock.

Analyst Ratings Changes

Several equities analysts have issued reports on the stock. Weiss Ratings restated a “hold (c-)” rating on shares of Chemed in a research note on Wednesday, January 21st. Royal Bank Of Canada lowered their price target on Chemed from $589.00 to $572.00 and set an “outperform” rating on the stock in a report on Monday, November 10th. Zacks Research upgraded Chemed from a “strong sell” rating to a “hold” rating in a research note on Thursday, October 30th. Finally, Jefferies Financial Group cut Chemed from a “buy” rating to a “hold” rating in a research report on Thursday, January 22nd. Three investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $555.50.

Insider Activity

In related news, CEO Kevin J. Mcnamara sold 2,000 shares of the stock in a transaction that occurred on Monday, November 24th. The shares were sold at an average price of $437.55, for a total value of $875,100.00. Following the completion of the sale, the chief executive officer directly owned 94,197 shares of the company’s stock, valued at approximately $41,215,897.35. This represents a 2.08% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Company insiders own 3.29% of the company’s stock.

Chemed Stock Performance

NYSE CHE opened at $447.56 on Friday. The business’s fifty day moving average is $436.81 and its 200 day moving average is $441.97. Chemed Corporation has a fifty-two week low of $408.42 and a fifty-two week high of $623.60. The company has a market capitalization of $6.34 billion, a PE ratio of 23.67, a price-to-earnings-growth ratio of 2.18 and a beta of 0.44.

Chemed Company Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.